Faculty of Pharmacy Newsletter:@0.147970:0.965677:0.401979:0.965677:0.401979:0.947594:0.147970:0.947594:0.011291:0.009239:0.008205:0.010274:0.005137:0.006153:0.009239:0.004620:0.009239:0.006153:0.004620:0.011291:0.010274:0.009239:0.008205:0.015393:0.009239:0.008205:0.009239:0.004620:0.013342:0.008205:0.013342:0.007188:0.005137:0.008205:0.006153:0.006153:0.008205:0.008205
44:@0.104524:0.971012:0.136879:0.971012:0.136879:0.940075:0.104524:0.940075:0.015815:0.016540
Chapter VI:@0.103809:0.063855:0.218582:0.063855:0.218582:0.040840:0.103809:0.040840:0.016980:0.013076:0.011759:0.013076:0.007832:0.010442:0.010021:0.005456:0.016980:0.009149
Journal of Biochemical and Molecular Toxicology:@0.185150:0.095118:0.814870:0.095118:0.814870:0.066489:0.185150:0.066489:0.015119:0.015119:0.016812:0.011763:0.016812:0.015119:0.008406:0.007560:0.015119:0.010069:0.007560:0.020169:0.008406:0.015119:0.013426:0.016812:0.013426:0.023525:0.008406:0.013426:0.015119:0.008406:0.007560:0.015119:0.016812:0.015119:0.007560:0.026882:0.015119:0.008406:0.013426:0.013426:0.016812:0.008406:0.015119:0.011763:0.007560:0.015675:0.015119:0.015119:0.008406:0.013426:0.015119:0.008406:0.015119:0.015119:0.013426
2023 Mar;37(3):e23266:@0.401180:0.116686:0.598816:0.116686:0.598816:0.097600:0.401180:0.097600:0.010079:0.010079:0.010079:0.010079:0.005040:0.017921:0.010079:0.007842:0.006713:0.010079:0.010079:0.006713:0.010079:0.006713:0.006713:0.008950:0.010079:0.010079:0.010079:0.010079:0.010079
Fingolimod attenuates ovalbumin-induced airway :@0.188767:0.161519:0.818838:0.161519:0.818838:0.132891:0.188767:0.132891:0.020169:0.008406:0.016812:0.015119:0.015119:0.008406:0.008406:0.023525:0.015119:0.015119:0.007560:0.015119:0.008406:0.008406:0.013426:0.016812:0.016812:0.015119:0.008406:0.013426:0.011763:0.007560:0.015119:0.013426:0.015119:0.008406:0.015119:0.016812:0.023525:0.008406:0.016812:0.010069:0.008406:0.016812:0.015119:0.016812:0.013426:0.013426:0.015119:0.007560:0.015119:0.008406:0.011763:0.020169:0.015119:0.013426:0.007560
inflammation via inhibiting MAPK/ERK signaling in mice:@0.136205:0.185275:0.863854:0.185275:0.863854:0.156647:0.136205:0.156647:0.008406:0.016812:0.008406:0.008406:0.015119:0.023525:0.023525:0.015119:0.008406:0.008406:0.015119:0.016812:0.007560:0.013426:0.008406:0.015119:0.007560:0.008406:0.016812:0.016812:0.008406:0.015119:0.008406:0.008406:0.008406:0.016812:0.015119:0.007560:0.026882:0.020169:0.018475:0.020169:0.008406:0.020169:0.020169:0.020169:0.007560:0.011763:0.008406:0.015119:0.016812:0.015119:0.008406:0.008406:0.016812:0.015119:0.007560:0.008406:0.016812:0.007560:0.023525:0.008406:0.013426:0.013426
Mirhan N. Makled , :@0.104762:0.303710:0.271317:0.303710:0.271317:0.284510:0.104762:0.284510:0.017921:0.005604:0.006713:0.010079:0.008950:0.010079:0.005040:0.014555:0.005040:0.005040:0.017921:0.008950:0.010079:0.005604:0.008950:0.010079:0.005870:0.005040:0.005040
1:@0.255362:0.297139:0.261238:0.297139:0.261238:0.285945:0.255362:0.285945:0.005876
Ahmed R. El-Sheakh:@0.271317:0.304009:0.453330:0.304009:0.453330:0.284282:0.271317:0.284282:0.014555:0.011208:0.016792:0.008950:0.011208:0.005040:0.014555:0.005040:0.005040:0.013446:0.005604:0.006713:0.011208:0.011208:0.008950:0.010079:0.011208:0.011208
1 2:@0.453346:0.297313:0.470138:0.297313:0.470138:0.285812:0.453346:0.285812:0.005876:0.005040:0.005876
,:@0.459222:0.304009:0.464262:0.304009:0.464262:0.284282:0.459222:0.284282:0.005040
 :@0.470138:0.303710:0.475178:0.303710:0.475178:0.284510:0.470138:0.284510:0.005040
1:@0.104762:0.320977:0.110638:0.320977:0.110638:0.309784:0.104762:0.309784:0.005876
 Department of Pharmacology and Toxicology, :@0.110638:0.327548:0.493135:0.327548:0.493135:0.308348:0.110638:0.308348:0.005013:0.014555:0.008950:0.010079:0.008950:0.006713:0.005604:0.015683:0.008950:0.010079:0.005604:0.004995:0.010079:0.006713:0.005013:0.011208:0.010079:0.008950:0.006713:0.015683:0.008950:0.008950:0.010079:0.005592:0.010079:0.010079:0.010079:0.005011:0.008950:0.010079:0.010079:0.004647:0.010906:0.010079:0.010079:0.005604:0.008950:0.010079:0.005604:0.010079:0.010079:0.008761:0.005040:0.005040
Faculty  of  Pharmacy,  Mansoura  University, :@0.104762:0.344653:0.493135:0.344653:0.493135:0.325453:0.104762:0.325453:0.011208:0.008950:0.008950:0.010079:0.005604:0.005604:0.010079:0.005040:0.008023:0.010079:0.006713:0.005040:0.008033:0.011208:0.010079:0.008950:0.006713:0.015683:0.008950:0.008950:0.008759:0.005040:0.005040:0.008033:0.017921:0.008950:0.010079:0.007842:0.010079:0.010079:0.006713:0.008950:0.005040:0.008033:0.014555:0.010079:0.005604:0.010079:0.008950:0.006713:0.007842:0.005604:0.005604:0.008765:0.005040:0.005040
Mansoura,  Egypt.:@0.104762:0.361757:0.255212:0.361757:0.255212:0.342557:0.104762:0.342557:0.017921:0.008950:0.010079:0.007842:0.010079:0.010079:0.006713:0.008950:0.005040:0.005040:0.006558:0.012317:0.010079:0.010079:0.010079:0.005604:0.005040
2:@0.104762:0.379024:0.110638:0.379024:0.110638:0.367831:0.104762:0.367831:0.005876
  Future  Studies  and  Risks  Management  & :@0.110638:0.385595:0.493133:0.385595:0.493133:0.366396:0.110638:0.366396:0.005040:0.006731:0.011208:0.010079:0.005604:0.010079:0.006713:0.008950:0.005040:0.006725:0.011208:0.005604:0.010079:0.010079:0.005604:0.008950:0.007842:0.005040:0.006727:0.008950:0.010079:0.010079:0.005040:0.006729:0.013446:0.005604:0.007842:0.010079:0.007842:0.005040:0.006735:0.017921:0.008950:0.010079:0.008950:0.010079:0.008950:0.015683:0.008950:0.010079:0.005604:0.005040:0.006715:0.015683:0.005040
National  Committee  of  Drugs,  Academy :@0.104762:0.402700:0.493144:0.402700:0.493144:0.383500:0.104762:0.383500:0.014555:0.008950:0.005604:0.005604:0.010079:0.010079:0.008950:0.005604:0.005040:0.014224:0.013446:0.010079:0.015683:0.015683:0.005604:0.005604:0.005604:0.008950:0.008950:0.005040:0.014212:0.010079:0.006713:0.005040:0.014236:0.014555:0.006713:0.010079:0.010079:0.007842:0.005040:0.005040:0.013131:0.014555:0.008950:0.008950:0.010079:0.008950:0.015683:0.010079:0.005040
of  Scientific  Research,  Ministry  of  Higher :@0.104762:0.419804:0.493135:0.419804:0.493135:0.400604:0.104762:0.400604:0.010079:0.006713:0.005040:0.008874:0.011208:0.008950:0.005604:0.008950:0.010079:0.005604:0.005604:0.005604:0.005604:0.008950:0.005040:0.008860:0.013446:0.008950:0.007842:0.008950:0.008950:0.006713:0.008950:0.010079:0.005040:0.005040:0.008864:0.017921:0.005604:0.010079:0.005604:0.006572:0.006572:0.006713:0.010079:0.005040:0.008874:0.010079:0.006713:0.005040:0.008874:0.014555:0.005604:0.010079:0.010079:0.008950:0.006713:0.005040
Education,  ElSayeda  Zeinab,  Egypt.:@0.104762:0.436908:0.438195:0.436908:0.438195:0.417709:0.104762:0.417709:0.012317:0.010079:0.010079:0.008950:0.008950:0.005604:0.005604:0.010079:0.010079:0.005040:0.005040:0.013722:0.012317:0.005604:0.011208:0.008950:0.010079:0.008950:0.010079:0.008950:0.005040:0.013726:0.012317:0.008950:0.005604:0.010079:0.008950:0.010079:0.005040:0.005040:0.013724:0.012317:0.010079:0.010079:0.010079:0.005604:0.005040
Abstract:@0.104762:0.460747:0.174027:0.460747:0.174027:0.441661:0.104762:0.441661:0.013446:0.010079:0.006632:0.006632:0.007842:0.010079:0.008950:0.005604
The current study was designed to investigate :@0.104762:0.484585:0.493146:0.484585:0.493146:0.465386:0.104762:0.465386:0.012317:0.010079:0.008950:0.007628:0.008950:0.010079:0.006713:0.006713:0.008950:0.010079:0.005604:0.007628:0.006572:0.006572:0.010079:0.010079:0.010079:0.007634:0.014555:0.008950:0.007842:0.007638:0.010079:0.008950:0.007842:0.005604:0.010079:0.010079:0.008950:0.010079:0.007626:0.005604:0.010079:0.007632:0.005604:0.010079:0.010079:0.008950:0.006572:0.006572:0.005604:0.010079:0.008950:0.005604:0.008950:0.005040
the potential anti-inflammatory and antioxidant :@0.104762:0.501690:0.493154:0.501690:0.493154:0.482490:0.104762:0.482490:0.005604:0.010079:0.008950:0.005697:0.010079:0.010079:0.005604:0.008950:0.010079:0.005604:0.005604:0.008950:0.005604:0.005681:0.008950:0.010079:0.005604:0.005604:0.006713:0.005604:0.010079:0.005604:0.005604:0.008950:0.015683:0.015683:0.008928:0.005604:0.010079:0.006713:0.010079:0.005699:0.008950:0.010079:0.010079:0.005699:0.008950:0.010079:0.005604:0.005604:0.010079:0.010079:0.005604:0.010079:0.008950:0.010079:0.005604:0.005040
effects of fingolimod against Ovalbumin (Ova)-:@0.104762:0.518794:0.488092:0.518794:0.488092:0.499594:0.104762:0.499594:0.008950:0.006088:0.006088:0.008950:0.008950:0.005604:0.007842:0.004862:0.010079:0.006713:0.004870:0.005604:0.005604:0.010079:0.010079:0.010079:0.005604:0.005604:0.015683:0.010079:0.010079:0.004862:0.008950:0.010079:0.008950:0.005604:0.010079:0.006572:0.006572:0.004868:0.014555:0.010079:0.008950:0.005604:0.010079:0.010079:0.015683:0.005604:0.010079:0.004860:0.006713:0.014555:0.010079:0.008950:0.006713:0.006713
induced allergic airway inflammation compared :@0.104762:0.535898:0.493148:0.535898:0.493148:0.516699:0.104762:0.516699:0.005604:0.010079:0.010079:0.010079:0.008950:0.008950:0.010079:0.004397:0.008950:0.005604:0.005604:0.008950:0.006336:0.010079:0.005604:0.008950:0.004399:0.008950:0.005604:0.006713:0.014555:0.008950:0.010079:0.004399:0.005604:0.010079:0.005604:0.005604:0.008950:0.015683:0.015683:0.008950:0.005604:0.005604:0.010079:0.010079:0.004387:0.008950:0.010079:0.015683:0.010079:0.008950:0.006713:0.008950:0.010079:0.005040
to dexamethasone. Fingolimod was given (0.5 :@0.104762:0.553003:0.493140:0.553003:0.493140:0.533803:0.104762:0.533803:0.005604:0.010079:0.007239:0.010079:0.008950:0.010079:0.008950:0.015683:0.008950:0.005604:0.010079:0.008950:0.007842:0.010079:0.010079:0.008950:0.005040:0.007231:0.011208:0.005604:0.010079:0.010079:0.010079:0.005604:0.005604:0.015683:0.010079:0.010079:0.007233:0.014555:0.008950:0.007842:0.007247:0.010079:0.005604:0.010079:0.008950:0.010079:0.007235:0.006713:0.010079:0.005040:0.010079:0.005040
mg/kg/day, p.o.) for sensitized mice 1 h before :@0.104762:0.570107:0.493148:0.570107:0.493148:0.550907:0.104762:0.550907:0.015683:0.010079:0.005604:0.010079:0.010079:0.005604:0.010079:0.008950:0.008757:0.005040:0.006088:0.010079:0.005040:0.010079:0.005040:0.006713:0.006088:0.006713:0.010079:0.006713:0.006088:0.007842:0.008950:0.010079:0.007842:0.005604:0.005604:0.005604:0.008950:0.008950:0.010079:0.006082:0.015683:0.005604:0.008950:0.008950:0.006076:0.010079:0.006086:0.010079:0.006088:0.010079:0.008950:0.006713:0.010079:0.006713:0.008950:0.005040
Ova challenge from Days 19 to 24. Fingolimod :@0.104762:0.587211:0.493148:0.587211:0.493148:0.568012:0.104762:0.568012:0.014555:0.010079:0.008950:0.005253:0.008950:0.010079:0.008950:0.005604:0.005604:0.008950:0.010079:0.010079:0.008934:0.005253:0.006713:0.006713:0.010079:0.015683:0.005251:0.014555:0.008950:0.010079:0.007842:0.005257:0.010079:0.010079:0.005253:0.005604:0.010079:0.005251:0.010079:0.010079:0.005040:0.005253:0.011208:0.005604:0.010079:0.010079:0.010079:0.005604:0.005604:0.015683:0.010079:0.010079:0.005040
significantly  inhibited  Ova-induced  elevation :@0.104762:0.604316:0.493150:0.604316:0.493150:0.585116:0.104762:0.585116:0.007842:0.005604:0.010079:0.010079:0.005604:0.005604:0.005604:0.008950:0.008950:0.010079:0.005604:0.005604:0.010079:0.005040:0.006279:0.005604:0.010079:0.010079:0.005604:0.010079:0.005604:0.005604:0.008950:0.010079:0.005040:0.006277:0.014555:0.010079:0.008950:0.006713:0.005604:0.010079:0.010079:0.010079:0.008950:0.008950:0.010079:0.005040:0.006281:0.008950:0.005604:0.008950:0.010079:0.008950:0.005604:0.005604:0.010079:0.010079:0.005040
of inflammatory cells and eosinophils numbers :@0.104762:0.621420:0.493140:0.621420:0.493140:0.602220:0.104762:0.602220:0.010079:0.006713:0.006122:0.005604:0.010079:0.005604:0.005604:0.008950:0.015683:0.015683:0.008950:0.005604:0.010079:0.006713:0.010079:0.006110:0.008950:0.008950:0.005604:0.005604:0.007842:0.006112:0.008950:0.010079:0.010079:0.006120:0.008950:0.010079:0.007842:0.005604:0.010079:0.010079:0.010079:0.010079:0.005604:0.005604:0.007842:0.006116:0.010079:0.010079:0.015683:0.010079:0.008950:0.006713:0.007842:0.005040
in  bronchoalveolar  lavage  fluid  (BALF)  and :@0.104762:0.638525:0.493138:0.638525:0.493138:0.619325:0.104762:0.619325:0.005604:0.010079:0.005040:0.005566:0.010079:0.006713:0.010079:0.010079:0.008950:0.010079:0.010079:0.008950:0.005604:0.010079:0.008950:0.010079:0.005604:0.008950:0.006713:0.005040:0.005552:0.005604:0.008950:0.010079:0.008950:0.010079:0.008950:0.005040:0.005558:0.005604:0.005604:0.010079:0.005604:0.010079:0.005040:0.005568:0.006713:0.013446:0.014555:0.012317:0.011208:0.006713:0.005040:0.005574:0.008950:0.010079:0.010079:0.005040
reduced  concentrations  of  immunoglobulin :@0.104762:0.655629:0.493156:0.655629:0.493156:0.636429:0.104762:0.636429:0.006713:0.008950:0.010079:0.010079:0.008950:0.008950:0.010079:0.005040:0.011886:0.008950:0.010079:0.010079:0.008950:0.008950:0.010079:0.005604:0.006713:0.008950:0.005604:0.005604:0.010079:0.010079:0.007842:0.005040:0.011875:0.010079:0.006713:0.005040:0.011896:0.005604:0.015683:0.015683:0.010079:0.010079:0.010079:0.010079:0.005604:0.010079:0.010079:0.010079:0.005604:0.005604:0.010079:0.005040
E  in  serum  and  of  sphingosine-1-phosphate, :@0.104762:0.672733:0.493144:0.672733:0.493144:0.653534:0.104762:0.653534:0.012317:0.005040:0.005673:0.005604:0.010079:0.005040:0.005677:0.007842:0.008950:0.006713:0.010079:0.015683:0.005040:0.005669:0.008950:0.010079:0.010079:0.005040:0.005673:0.010079:0.006713:0.005040:0.005677:0.007842:0.010079:0.010079:0.005604:0.010079:0.010079:0.010079:0.007842:0.005604:0.010079:0.008950:0.006713:0.010079:0.006713:0.010079:0.010079:0.010079:0.007842:0.010079:0.010079:0.008950:0.005604:0.008950:0.005040:0.005040
interleukin  (IL)-4,  and  IL-13  in  BALF. :@0.104762:0.689838:0.493134:0.689838:0.493134:0.670638:0.104762:0.670638:0.005604:0.010079:0.005604:0.008950:0.006713:0.005604:0.008950:0.010079:0.010079:0.005604:0.010079:0.005040:0.014157:0.006713:0.006713:0.012317:0.006713:0.006713:0.010079:0.005040:0.005040:0.014174:0.008950:0.010079:0.010079:0.005040:0.014174:0.006713:0.012317:0.006713:0.010079:0.010079:0.005040:0.014174:0.005604:0.010079:0.005040:0.014174:0.013446:0.014555:0.012317:0.009596:0.005040:0.005040
Fingolimod  inhibited  microvascular  leakage :@0.104762:0.706942:0.493150:0.706942:0.493150:0.687742:0.104762:0.687742:0.011208:0.005604:0.010079:0.010079:0.010079:0.005604:0.005604:0.015683:0.010079:0.010079:0.005040:0.008898:0.005604:0.010079:0.010079:0.005604:0.010079:0.005604:0.005604:0.008950:0.010079:0.005040:0.008892:0.015683:0.005604:0.008940:0.006713:0.010079:0.010079:0.008950:0.007842:0.008950:0.010079:0.005604:0.008950:0.006713:0.005040:0.008900:0.005604:0.008950:0.008950:0.010079:0.008950:0.010079:0.008950:0.005040
and edema as reflected by the decreased lung/:@0.104762:0.724046:0.488102:0.724046:0.488102:0.704847:0.104762:0.704847:0.008950:0.010079:0.010079:0.007106:0.008950:0.010079:0.008950:0.015683:0.008950:0.007096:0.008950:0.007842:0.007108:0.006713:0.008950:0.005604:0.005604:0.008950:0.008950:0.005604:0.008950:0.010079:0.007096:0.010079:0.010079:0.007108:0.005604:0.010079:0.008950:0.007102:0.010079:0.008950:0.008950:0.006713:0.008950:0.008950:0.007842:0.008950:0.010079:0.007098:0.005604:0.010079:0.010079:0.010079:0.005604
body  weight  index.  These  findings  were :@0.104762:0.741151:0.493146:0.741151:0.493146:0.721951:0.104762:0.721951:0.010079:0.010079:0.010079:0.010079:0.005040:0.012242:0.014555:0.008950:0.005604:0.010079:0.010079:0.005604:0.005040:0.012244:0.005604:0.010079:0.010079:0.008950:0.010079:0.005040:0.005040:0.011871:0.012317:0.010079:0.008950:0.007842:0.008950:0.005040:0.012240:0.005604:0.005604:0.010079:0.010079:0.005604:0.010079:0.010079:0.007842:0.005040:0.012246:0.014555:0.008950:0.006713:0.008950:0.005040
supported  by  histopathological  examination :@0.104762:0.758255:0.493164:0.758255:0.493164:0.739055:0.104762:0.739055:0.007842:0.010079:0.010079:0.010079:0.010079:0.006713:0.005604:0.008950:0.010079:0.005040:0.010116:0.010079:0.010079:0.005040:0.010120:0.010079:0.005604:0.006572:0.006572:0.010079:0.010079:0.008950:0.005604:0.010079:0.010079:0.005604:0.010079:0.010079:0.005604:0.008950:0.008950:0.005604:0.005040:0.010108:0.008950:0.010079:0.008950:0.015683:0.005604:0.010079:0.008950:0.005604:0.005604:0.010079:0.010079:0.005040
results  showing  that  fingolimod  substantially :@0.104762:0.775359:0.493142:0.775359:0.493142:0.756160:0.104762:0.756160:0.006713:0.008950:0.007842:0.010079:0.005604:0.005604:0.007842:0.005040:0.005471:0.007842:0.010079:0.010079:0.014555:0.005604:0.010079:0.010079:0.005040:0.005473:0.005604:0.010079:0.008950:0.005604:0.005040:0.005465:0.005604:0.005604:0.010079:0.010079:0.010079:0.005604:0.005604:0.015683:0.010079:0.010079:0.005040:0.005465:0.007842:0.010079:0.010079:0.006572:0.006572:0.008950:0.010079:0.005604:0.005604:0.008950:0.005604:0.005604:0.010079:0.005040
decreased perivascular edema and inflammatory :@0.104762:0.792464:0.493156:0.792464:0.493156:0.773264:0.104762:0.773264:0.010079:0.008950:0.008950:0.006713:0.008950:0.008950:0.007842:0.008950:0.010079:0.003752:0.010079:0.008950:0.006713:0.005604:0.010079:0.008950:0.007842:0.008950:0.010079:0.005604:0.008950:0.006713:0.003752:0.008950:0.010079:0.008950:0.015673:0.008950:0.003760:0.008950:0.010079:0.010079:0.003762:0.005604:0.010079:0.005604:0.005604:0.008950:0.015683:0.015683:0.008950:0.005604:0.010079:0.006713:0.010079:0.005040
cell  infiltration.  Fingolimod  also  attenuated :@0.104762:0.809568:0.493158:0.809568:0.493158:0.790369:0.104762:0.790369:0.008950:0.008950:0.005604:0.005604:0.005040:0.008620:0.005604:0.010079:0.005604:0.005604:0.005604:0.005604:0.006713:0.008950:0.005604:0.005588:0.010079:0.010079:0.005040:0.005040:0.008632:0.011208:0.005604:0.010079:0.010079:0.010079:0.005604:0.005604:0.015673:0.010079:0.010079:0.005040:0.008634:0.008950:0.005604:0.007842:0.010079:0.005040:0.008630:0.008950:0.005604:0.005604:0.008950:0.010079:0.010079:0.008950:0.005604:0.008950:0.010079:0.005040
Ova-induced  oxidative  stress  as  evidenced :@0.104762:0.826673:0.493150:0.826673:0.493150:0.807473:0.104762:0.807473:0.014555:0.010079:0.008950:0.006713:0.005604:0.010079:0.010079:0.010079:0.008950:0.008950:0.010079:0.005040:0.010253:0.010079:0.010079:0.005604:0.010079:0.008950:0.005604:0.005604:0.010079:0.008950:0.005040:0.010247:0.006572:0.006572:0.006713:0.008950:0.007842:0.007842:0.005040:0.010273:0.008950:0.007842:0.005040:0.010261:0.008950:0.010079:0.005604:0.010079:0.008950:0.010079:0.008950:0.008950:0.010079:0.005040
by  decreased  malondialdehyde  concentration :@0.104762:0.843777:0.493168:0.843777:0.493168:0.824577:0.104762:0.824577:0.010079:0.010079:0.005040:0.006691:0.010079:0.008950:0.008950:0.006713:0.008950:0.008950:0.007842:0.008950:0.010079:0.005040:0.006691:0.015683:0.008950:0.005604:0.010079:0.010079:0.010079:0.005604:0.008950:0.005604:0.010079:0.008928:0.010079:0.010079:0.010079:0.008950:0.005040:0.006687:0.008950:0.010079:0.010079:0.008950:0.008950:0.010079:0.005604:0.006713:0.008950:0.005604:0.005604:0.010079:0.010079:0.005040
along with increasing concentrations of reduced :@0.104762:0.860881:0.493152:0.860881:0.493152:0.841682:0.104762:0.841682:0.008950:0.005604:0.010079:0.010079:0.010079:0.004340:0.014555:0.005604:0.005604:0.010079:0.004344:0.005604:0.010079:0.008950:0.006713:0.008950:0.008950:0.007842:0.005604:0.010079:0.010079:0.004334:0.008950:0.010079:0.010079:0.008950:0.008950:0.010079:0.005604:0.006713:0.008950:0.005604:0.005604:0.010079:0.010079:0.007842:0.004336:0.010079:0.006713:0.004348:0.006713:0.008950:0.010079:0.010079:0.008950:0.008950:0.010079:0.005040
glutathione  and  superoxide  dismutase  in  lung :@0.104762:0.877986:0.493138:0.877986:0.493138:0.858786:0.104762:0.858786:0.010079:0.005604:0.010079:0.005604:0.008950:0.005604:0.010079:0.005604:0.010079:0.010079:0.008950:0.005040:0.003528:0.008950:0.010079:0.010079:0.005040:0.003546:0.007842:0.010079:0.010079:0.008950:0.006713:0.010079:0.010079:0.005604:0.010079:0.008950:0.005040:0.003542:0.010079:0.005604:0.007842:0.015683:0.010079:0.005604:0.008950:0.007842:0.008950:0.005040:0.003538:0.005604:0.010079:0.005040:0.003544:0.005604:0.010079:0.010079:0.010079:0.005040
tissues. Fingolimod also significantly decreased :@0.104762:0.895090:0.493146:0.895090:0.493146:0.875890:0.104762:0.875890:0.005604:0.005604:0.007842:0.007842:0.010079:0.008950:0.007842:0.005040:0.004711:0.011208:0.005604:0.010079:0.010079:0.010079:0.005604:0.005604:0.015683:0.010079:0.010079:0.004699:0.008950:0.005604:0.007842:0.010079:0.004707:0.007842:0.005604:0.010079:0.010079:0.005604:0.005604:0.005604:0.008950:0.008950:0.010079:0.005604:0.005604:0.010079:0.004697:0.010079:0.008950:0.008950:0.006713:0.008950:0.008950:0.007842:0.008950:0.010079:0.005040
monocyte  chemoattractant  protein-1  (MCP-:@0.104762:0.912194:0.488088:0.912194:0.488088:0.892995:0.104762:0.892995:0.015683:0.010079:0.010079:0.010079:0.008950:0.010079:0.005604:0.008950:0.005040:0.010021:0.008950:0.010079:0.008950:0.015683:0.010079:0.008950:0.005604:0.005604:0.006713:0.008950:0.008950:0.005604:0.008950:0.010079:0.005604:0.005040:0.009999:0.010079:0.006713:0.010079:0.005604:0.008950:0.005604:0.010079:0.006713:0.010079:0.005040:0.010025:0.006713:0.017921:0.013446:0.011208:0.006713
1), p-ERK, and p-P38 in lung tissues of Ova-:@0.104762:0.929299:0.488102:0.929299:0.488102:0.910099:0.104762:0.910099:0.010079:0.006713:0.005040:0.007465:0.010079:0.006713:0.012317:0.013446:0.014555:0.005040:0.007467:0.008950:0.010079:0.010079:0.007463:0.010079:0.006713:0.011208:0.010079:0.010079:0.007467:0.005604:0.010079:0.007461:0.005604:0.010079:0.010079:0.010079:0.007463:0.005604:0.005604:0.007842:0.007842:0.010079:0.008950:0.007842:0.007465:0.010079:0.006713:0.007463:0.014555:0.010079:0.008950:0.006713
challenged  mice.  In  conclusion,  the  current :@0.511904:0.590017:0.900286:0.590017:0.900286:0.570817:0.511904:0.570817:0.008950:0.010079:0.008950:0.005604:0.005604:0.008950:0.010079:0.010079:0.008950:0.010079:0.005040:0.007128:0.015683:0.005604:0.008950:0.008950:0.005040:0.005040:0.007134:0.006713:0.010079:0.005040:0.007146:0.008950:0.010079:0.010079:0.008950:0.005604:0.010079:0.007842:0.005604:0.010079:0.010079:0.005040:0.005040:0.007136:0.005604:0.010079:0.008950:0.005040:0.007140:0.008950:0.010079:0.006713:0.006713:0.008950:0.010079:0.005604:0.005040
study  demonstrated  the  anti-inflammatory and :@0.511904:0.607121:0.900280:0.607121:0.900280:0.587921:0.511904:0.587921:0.006572:0.006572:0.010079:0.010079:0.010079:0.005040:0.003054:0.010079:0.008950:0.015683:0.010079:0.010079:0.006572:0.006572:0.006713:0.008950:0.005604:0.008950:0.010079:0.005040:0.003038:0.005604:0.010079:0.008950:0.005040:0.003040:0.008950:0.010079:0.005604:0.005604:0.006713:0.005604:0.010079:0.005604:0.005604:0.008950:0.015683:0.015683:0.008950:0.005604:0.010079:0.006713:0.010079:0.008061:0.008950:0.010079:0.010079:0.005040
antioxidant  effects  of  fingolimod  in  allergic :@0.511904:0.624225:0.900286:0.624225:0.900286:0.605026:0.511904:0.605026:0.008950:0.010079:0.005604:0.005604:0.010079:0.010079:0.005604:0.010079:0.008950:0.010079:0.005604:0.005040:0.006769:0.008950:0.006088:0.006088:0.008950:0.008950:0.005604:0.007842:0.005040:0.006783:0.010079:0.006713:0.005040:0.006787:0.005604:0.005604:0.010079:0.010079:0.010079:0.005604:0.005604:0.015683:0.010079:0.010079:0.005040:0.006779:0.005604:0.010079:0.005040:0.006785:0.008950:0.005604:0.005604:0.008950:0.006336:0.010079:0.005604:0.008950:0.005040
airway  inflammation  that  might  be  associated :@0.511904:0.641330:0.900298:0.641330:0.900298:0.622130:0.511904:0.622130:0.008950:0.005604:0.006713:0.014555:0.008950:0.010079:0.005040:0.003324:0.005604:0.010079:0.005604:0.005604:0.008950:0.015683:0.015683:0.008950:0.005604:0.005604:0.010079:0.010079:0.005040:0.003316:0.005604:0.010079:0.008950:0.005604:0.005040:0.003320:0.015683:0.005604:0.010079:0.010079:0.005604:0.005040:0.003320:0.010079:0.008950:0.005040:0.003326:0.008950:0.007842:0.007842:0.010079:0.008950:0.005604:0.008950:0.005604:0.008950:0.010079:0.005040
with  the  downregulation  of  mitogen  activated :@0.511904:0.658434:0.900300:0.658434:0.900300:0.639234:0.511904:0.639234:0.014555:0.005604:0.005604:0.010079:0.005040:0.003104:0.005604:0.010079:0.008950:0.005040:0.003100:0.010079:0.010079:0.014555:0.010079:0.006713:0.008950:0.010079:0.010079:0.005604:0.008950:0.005604:0.005604:0.010079:0.010079:0.005040:0.003094:0.010079:0.006713:0.005040:0.003106:0.015683:0.005604:0.005604:0.010079:0.010079:0.008950:0.010079:0.005040:0.003094:0.008950:0.008950:0.005604:0.005604:0.010079:0.008950:0.005604:0.008950:0.010079:0.005040
kinases  signaling  to  decrease  T  helper  2 :@0.511904:0.675538:0.900278:0.675538:0.900278:0.656339:0.511904:0.656339:0.010079:0.005604:0.010079:0.008950:0.007842:0.008950:0.007842:0.005040:0.010456:0.007842:0.005604:0.010079:0.010079:0.008950:0.005604:0.005604:0.010079:0.010079:0.005040:0.010448:0.005604:0.010079:0.005040:0.010454:0.010079:0.008950:0.008950:0.006713:0.008950:0.008950:0.007842:0.008950:0.005040:0.010083:0.011950:0.005040:0.010458:0.010079:0.008950:0.005604:0.010079:0.008950:0.006713:0.005040:0.010450:0.010079:0.005040
cytokine secretion (IL-4 and IL-13) and MCP-:@0.511904:0.692643:0.895234:0.692643:0.895234:0.673443:0.511904:0.673443:0.008950:0.010079:0.005604:0.010079:0.010079:0.005604:0.010079:0.008950:0.006404:0.007842:0.008950:0.008950:0.006713:0.008950:0.005604:0.005604:0.010079:0.010079:0.006408:0.006713:0.006713:0.012317:0.006713:0.010079:0.006415:0.008950:0.010079:0.010079:0.006419:0.006713:0.012317:0.006713:0.010079:0.010079:0.006713:0.006415:0.008950:0.010079:0.010079:0.006415:0.017921:0.013446:0.011208:0.006713
1  expression,  along  with  the  inhibition  of :@0.511904:0.709747:0.900276:0.709747:0.900276:0.690547:0.511904:0.690547:0.010079:0.005040:0.008553:0.008950:0.010079:0.010079:0.006713:0.008950:0.007842:0.007842:0.005604:0.010079:0.010079:0.005040:0.005040:0.008549:0.008950:0.005604:0.010079:0.010079:0.010079:0.005040:0.008545:0.014555:0.005604:0.005604:0.010079:0.005040:0.008549:0.005604:0.010079:0.008950:0.005040:0.008545:0.005604:0.010079:0.010079:0.005604:0.010079:0.005604:0.005604:0.005604:0.010079:0.010079:0.005040:0.008535:0.010079:0.006713:0.005040
oxidative  stress. :@0.511904:0.726851:0.654773:0.726851:0.654773:0.707652:0.511904:0.707652:0.010079:0.010079:0.005604:0.010079:0.008950:0.005604:0.005604:0.010079:0.008950:0.005040:0.008229:0.006572:0.006572:0.006713:0.008950:0.007842:0.007842:0.005040:0.005040
https://doi.org/10.1002/jbt.23266:@0.511904:0.750690:0.778667:0.750690:0.778667:0.731490:0.511904:0.731490:0.010079:0.005604:0.005604:0.010079:0.007842:0.005604:0.005604:0.005604:0.010079:0.010079:0.005604:0.005040:0.010079:0.006332:0.010079:0.005604:0.010079:0.010079:0.005040:0.010079:0.010079:0.010079:0.010079:0.005604:0.005604:0.010079:0.005604:0.005040:0.010079:0.010079:0.010079:0.010079:0.010079